 |
January-March 2016 Volume 5 | Issue 1
Page Nos. 1-33
Online since Tuesday, June 14, 2016
Accessed 53,117 times.
PDF access policy Journal allows immediate open access to content in HTML + PDF
|
| |
|
Show all abstracts Show selected abstracts Add to my list |
|
EDITORS PAGE |
|
|
|
Heralding a new era! |
p. 1 |
Ravi R Kasliwal |
[HTML Full text] [PDF] [Mobile Full text] [EPub] [Sword Plugin for Repository]Beta |
|
|
|
|
|
|
ORIGINAL ARTICLE |
 |
|
|
 |
Medication adherence and its determinants in myocardial infarction patients: An Indian scenario |
p. 2 |
Satish Balaji Gonarkar, Priti Pravin Dhande DOI:10.4103/2250-3528.183983 Background: Myocardial infarction (MI) is one of the leading causes of death. Along with lifestyle factors, poor medication adherence is one of the causes. This study was planned to find out the level of adherence in post-MI patients and its related factors.
Objectives: Monitoring medication adherence in patients of MI attending cardiac outpatient department and to reveal causes of nonadherence to drug therapy in them.
Methods: One hundred and one newly diagnosed MI patients were included in the study. Data collected were patient characteristics, habits, comorbidities, and drugs prescribed. Morisky 8 item scale was used to find out the medication adherence at the end of 1 st and 6 th month of cardiac event. Data were analyzed using McNemar test, Chi-square test, and logistic regression analysis.
Results: Most common preventive cardiovascular drugs given were aspirin, clopidogrel, and statins, 98%, 88.1%, and 90%, respectively. Medication adherence at 6 th month post-MI was significantly decreased compared to 1 st month (P < 0.0001). Factors which were related to good adherence were associated comorbidities such as hypertension (P = 0.017), age group of 56-65 years (P = 0.049), higher education (P = 0.045), employees (P = 0.008), and nonsmoker (P = 0.023). Determinants associated with poor adherence were affordability (P = 0.02) and medication complexity (P = 0.03).
Conclusion: Medication adherence in post-MI subjects of our study was seen to be reducing over 6 months due to factors such as low monthly income and low educational status of the subjects. Employed, higher educated, and those with comorbidities showed good adherence. |
[ABSTRACT] [HTML Full text] [PDF] [Mobile Full text] [EPub] [Citations (1) ] [Sword Plugin for Repository]Beta |
|
|
|
|
|
|
REVIEW ARTICLES |
 |
|
|
 |
Oats: A multi-functional grain  |
p. 9 |
Purvi Varma, Hitha Bhankharia, Shikha Bhatia DOI:10.4103/2250-3528.183984 Oats are predominantly a European and North American crop, as they have cool moist climate; Russia, Canada, the United States, Finland, and Poland are leading oat producing countries. Oats have been used as livestock and human foods since ancient times. Oats (Avena sativa) is a class of cereal grain essentially grown for human consumption as well as for livestock fodder. Food industry fundamentally alter agricultural commodities into foods making it edible, palatable as well as appealing; by innumerable physical and chemical operations increasing shelf-life, bioavailability of the nutrients, stabilizing colour, flavour along with increase in the economic value of the grain. Recent observational and human interventional studies indicate that oats can have an impact on various non-communicable diseases like cardiovascular disease, diabetes; obesity and hypertension etc. Therefore it is important to increase awareness of oats and its health benefits among individuals thereby encouraging them to increase the frequency of oats in the diet. In the year 1997, USFDA approved the use of a health claim "3g/day of oat Beta- glucan may help lower blood total and low-density lipoprotein (LDL-C) cholesterol". Over all consumption of oats has increased in the recent years due to its nutritional benefits; presence of Beta-glucan, antioxidants like Avenanthramides, vitamin E (tocotrienols and tocopherols). |
[ABSTRACT] [HTML Full text] [PDF] [Mobile Full text] [EPub] [Citations (16) ] [Sword Plugin for Repository]Beta |
|
|
|
|
|
|
Management options for coronary microvascular dysfunction: Present status and future perspectives |
p. 18 |
Sita Ram Mittal DOI:10.4103/2250-3528.184011 Coronary micro vessels are not visible on coronary angiography. These include prearterioles, arterioles, and capillaries. Significant number of patients of angina have coronary microvascular dysfunction alone or in combination with stenosis and/or spasm of epicardial coronary arteries. Its management is challenging. Several different therapeutic options have been tried with variable success. The present review provides overview of the available evidence with various therapeutic modalities for the treatment of microvascular angina. |
[ABSTRACT] [HTML Full text] [PDF] [Mobile Full text] [EPub] [Citations (2) ] [Sword Plugin for Repository]Beta |
|
|
|
|
|
|
BRIEF REVIEW |
 |
|
|
|
Hypertension and sleep apnea: The Deadly Duo |
p. 25 |
Navneet Wadhwa, Neeraj Tewari DOI:10.4103/2250-3528.184012 Obstructive Sleep Apnea is one of the most common cause of the secondary cause of consistent raised blood pressure. Evidence, consistently demonstrates that sleep apnea is a major modifiable risk factor of hypertension. Resistant hypertension has a strong correlation with OSA. There needs to be a strong emphasis for the effective therapeutic strategies to simultaneously improve the management of OSA and hypertension. |
[ABSTRACT] [HTML Full text] [PDF] [Mobile Full text] [EPub] [Sword Plugin for Repository]Beta |
|
|
|
|
|
|
EDITORIAL |
 |
|
|
|
Hypertension with obstructive sleep apnea |
p. 29 |
Bornali Datta, Ashish Kumar Prakash DOI:10.4103/2250-3528.184013 |
[HTML Full text] [PDF] [Mobile Full text] [EPub] [Citations (1) ] [Sword Plugin for Repository]Beta |
|
|
|
|
|
|
BOOKS AND TRIALS |
 |
|
|
|
Recent trials in cardiology: Newer evidence in management of coronary artery disease
|
p. 31 |
Gagandeep Singh Wander DOI:10.4103/2250-3528.184014 |
[HTML Full text] [PDF] [Mobile Full text] [EPub] [Sword Plugin for Repository]Beta |
|
|
|
|
|